Stay updated on Long-Term Follow-Up of Dupilumab Safety in Asthma Clinical Trial
Sign up to get notified when there's something new on the Long-Term Follow-Up of Dupilumab Safety in Asthma Clinical Trial page.

Latest updates to the Long-Term Follow-Up of Dupilumab Safety in Asthma Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange Detected- Added a government-operating-status notice and a new v3.2.0 revision tag. - Removed the prior v3.1.0 revision tag.SummaryDifference3%
- Check21 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedMinor release update: version changed from v3.0.1 to v3.0.2, and the 'Back to Top' link was removed. No changes to core content, pricing, stock availability, or time slot availability.SummaryDifference0.2%
- Check42 days agoChange DetectedThe web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content.SummaryDifference0.2%
- Check49 days agoChange DetectedThe web page has undergone significant updates, including the addition of multiple facility names and locations across various countries, while also removing several previously listed locations. Notably, the revision number has been updated from v2.16.12 to v3.0.0.SummaryDifference7%
- Check64 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to Long-Term Follow-Up of Dupilumab Safety in Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-Term Follow-Up of Dupilumab Safety in Asthma Clinical Trial page.